论文部分内容阅读
目的:分析六味地黄丸与甲钴胺联合应用于糖尿病周围神经病变患者的临床疗效。方法:将80例糖尿病周围神经病变患者随机分成两组,对照组40例给予常规治疗,实验组40例在常规治疗的基础上给予六味地黄丸与甲钴胺联合治疗,4周为1个疗程。对比分析两组患者的临床疗效。结果:对照组治疗总有效率为77.5%,实验组总有效率为92.5%,两组差异较大,有统计学意义(P<0.05)。结论:相比于常规治疗,六味地黄丸与甲钴胺联合应用于糖尿病周围神经病变患者的临床疗效更优,在提升周围神经传导速度的同时,不良反应也很少,应在临床治疗中普及推广。
Objective: To analyze the clinical efficacy of Liuweidihuangwan combined with mecobalamin in patients with diabetic peripheral neuropathy. Methods: 80 patients with diabetic peripheral neuropathy were randomly divided into two groups, the control group of 40 patients given conventional treatment, 40 patients in the experimental group on the basis of routine treatment given Liu Wei Di Huang Wan and mecobalamin combination therapy, 4 weeks for a course of treatment . Comparative analysis of two groups of patients with clinical efficacy. Results: The total effective rate of the control group was 77.5%, and the total effective rate of the experimental group was 92.5%. There was significant difference between the two groups (P <0.05). Conclusion: Compared with conventional treatment, Liu Wei Di Huang Wan and mecobalamin combination of diabetic peripheral neuropathy patients with better clinical efficacy in improving the peripheral nerve conduction velocity, the side effects are rare, should be popularized in clinical treatment Promotion.